Cargando…
Pyroptosis: A new insight of non-small-cell lung cancer treatment
Non-small cell lung cancer (NSCLC) has become one of the most common malignant tumors. Emerging evidence has shown that tumor resistance to apoptosis by damaging or bypassing apoptotic cell death is a major contributor to poor responses to therapy in patients with NSCLC. Pyroptosis is a new type of...
Autores principales: | Chen, Xi, Wu, Jianzhang, Wang, Jiabing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746897/ https://www.ncbi.nlm.nih.gov/pubmed/36523974 http://dx.doi.org/10.3389/fonc.2022.1013544 |
Ejemplares similares
-
Pyroptosis, a New Breakthrough in Cancer Treatment
por: Wu, Dengqiang, et al.
Publicado: (2021) -
Pyroptosis: the dawn of a new era in endometrial cancer treatment
por: Peng, Tian, et al.
Publicado: (2023) -
Current treatments for non-small cell lung cancer
por: Guo, Qianqian, et al.
Publicado: (2022) -
The Treatment of Metastatic Non-Small Cell Lung Cancer in a New Era of Personalized Medicine
por: Hirsh, Vera
Publicado: (2015) -
Efficacy and safety of nintedanib in patients with non-small cell lung cancer, and novel insights in radiation-induced lung toxicity
por: Yan, Shu, et al.
Publicado: (2023)